Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

US Patent 10751332 · Granted Aug 25, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors2025
Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors2025
Synchronous business process execution engine for action orchestration in a sing2025
Heterocyclic compounds as pad inhibitors2025
P2X3 and/or P2X2/3 compounds and methods2024
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2024
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2024
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2024
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2024
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2024
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2024
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2024